Two factors that influence CV risk the most in diabetics include HTN and
hyperlipidemia. Caduet contains amlodipine for BP and atorvastatin for
lipid reduction. Clinical trials have demonstrated efficacy of
atorvastatin in CV protection in diabetics REGARDLESS of baseline lipid
levels.
POSTED BY: STEVEN AJLUNI, MD
No comments:
Post a Comment